Table 3 Univariate and multivariate analyses of risk factors for POD24 in DLBC - PCNSL.

From: Prognostic significance of POD24 in primary central nervous system diffuse large B-cell lymphoma: a retrospective study

 

Univariate

Multivariate

Factors

OR (95%CI)

P value

OR (95%CI)

P value

Age

1.13 (0.44–2.91)

0.80

  

Gender, female

0.62 (0.26–1.49)

0.29

  

β2M > 2.7 µg/mL

6.00 (0.70–51.58)

0.103

  

D-Dimer > 2 mg/L

1.05 (0.39–2.85)

0.92

  

KPS scores

0.97 (0.94–1.00)

0.05

  

MSKCC

0.96 (0.52–1.79)

0.90

  

GCB subtype

2.35 (0.79–7.05)

0.13

  

Ki 67 ≥ 80%

0.72 (0.29–1.81)

0.49

  

ECOG score > 2

2.58 (0.66–10.20)

0.18

  

LDH > 225 u/L

5.05 (1.05–24.26)

0.04

12.00 (1.27–113.58)

0.03

TG > 1.7 mmol/L

3.89 (1.14–13.29)

0.03

4.88 (1.02–23.33)

0.047

CHOL > 5.2 mmol/L

1.11 (0.37–3.33)

0.86

  

CREA

0.99 (0.97–1.02)

0.59

  

Elevated protein levels in CSF

0.75 (0.17–3.31)

0.71

  

Albumin < 40 g/L

1.04 (0.43–2.49)

0.93

  

HbsAg positive

3.05 (0.61–15.34)

0.18

  

WBRT

1.23 (0.27–5.54)

0.79

  

Excision of intracranial tumor

0.16 (0.03–0.76)

0.02

  

Residual parenchymal central system lymphoma

4.05 (1.51–10.86)

0.005

  

Regimens without RTX

1.91 (0.71–5.14)

0.20

  

ASCT

0.83 (0.21–3.36)

0.80

  

Non-responsive diseases

6.36 (1.90–21.34)

0.003

9.39 (2.16–40.87)

0.003